CMR Naviscan Corporation
Developer and distributor of dedicated breast molecular imaging systems and related clinical workflows. The company promotes radionuclide-based breast imaging (molecular breast imaging and breast PET/PEM) as adjunctive and diagnostic tools for women with dense breast tissue and other indications, cites clinical evidence and publications, and maintains a global sales and service network. Headquartered in Carlsbad, California; US FDA registered.
Industries
N/A
Nr. of Employees
small (1-50)
CMR Naviscan Corporation
2720 Loker Avenue West, Suite O, Carlsbad, California 92010
Products
Dual-head solid-state molecular breast imaging system (dedicated MBI)
A dedicated planar dual-head, solid-state digital imaging system for breast molecular imaging. Designed to produce high-resolution functional images for adjunct screening and diagnostic evaluation in dense breasts, with reported ~1.6 mm intrinsic spatial resolution and energy resolution under 5% FWHM.
Dual-head solid-state molecular breast imaging system (dedicated MBI)
A dedicated planar dual-head, solid-state digital imaging system for breast molecular imaging. Designed to produce high-resolution functional images for adjunct screening and diagnostic evaluation in dense breasts, with reported ~1.6 mm intrinsic spatial resolution and energy resolution under 5% FWHM.
Services
Sales distribution and technical/service support through a global network of representatives and service centers.
Sales distribution and technical/service support through a global network of representatives and service centers.
Expertise Areas
- Molecular breast imaging (MBI)
- Dedicated breast PET / positron-emission mammography (PEM)
- MBI-guided biopsy procedures
- Low-dose nuclear imaging protocols
Key Technologies
- Cadmium zinc telluride (CZT) solid-state detectors
- Dual-head digital gamma camera architecture
- Radionuclide photon detection and planar gamma imaging
- Positron-emission mammography (PEM) / dedicated breast PET
News & Updates
Patient and clinician perspectives on breast density and supplemental imaging options following mammography.
Local news coverage describing a case where dedicated breast molecular imaging detected cancer that was undetectable on prior mammography.
Summary of expert workgroup recommendations for appropriate use criteria published in the Journal of Nuclear Medicine Technology.
Bronze Award in the Radiological and Electromechanical Devices category (17th Annual MDEA).
Recipient of Frost & Sullivan 2014 Best Practices Award for product leadership in global breast imaging systems.
Patient and clinician perspectives on breast density and supplemental imaging options following mammography.
Local news coverage describing a case where dedicated breast molecular imaging detected cancer that was undetectable on prior mammography.
Summary of expert workgroup recommendations for appropriate use criteria published in the Journal of Nuclear Medicine Technology.
Bronze Award in the Radiological and Electromechanical Devices category (17th Annual MDEA).
Recipient of Frost & Sullivan 2014 Best Practices Award for product leadership in global breast imaging systems.